GLI1 and cancer: These results indicate that TSPAN8-enhanced and ATXN3-mediated PTCH1 expression promotes the binding of GRK2 to PTCH1 and SMO, leading to enhanced SMO phosphorylation, activated GLI1 transcriptional activity, enhanced cancer cell stemness, and resistance to chemotherapeutic agents.